Concepedia

Bruce E. Sands

BE

Statistics

Publications

300

Citations

54.2K

H-Index

94

Active since

1993

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of California San Diego

Massachusetts General Hospital

Western University

Harvard University

Bruce E. Sands is an author at Icahn School of Medicine at Mount Sinai specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

1993–2025

300

Publications

300

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Xochitl C. Morgan, Timothy L. Tickle, Harry Sokol et al. · Genome biology · 2012 · 2.8K citations · Full text

, , +17

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

, , +14

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

1–5 of 300